This may be due to a pre-existent heterogeneity in PD-L1 methylation patterns in tumor cells or to a tumor cell evolution and switch-off the PD-L1 expression through epigenetic modulation induced by the selective pressure of the drug. Here, CD274 is linked to neoplasm.